Although single treatment with TAS-115 or anti-PD-1 antibody moderately suppressed tumor growth, combined treatment with TAS-115 and anti-PD-1 antibody exhibited greater tumor growth inhibition than either treatment alone (Fig. 5A). The gene discussed is PDCD1; the disease is neoplasm.